Sign In
to Vote &
Create Storyboards.
 

Analyst Moves: ABT, ENDP

Forbes - 4 Jan 2013 22:27
Abbott Laboratories (ABT) was downgraded by Deutsche Bank (DB) to hold from buy as the stock price has exceeded the previously set $33 target, and the firm believes it is fully valued.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard